• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食物对健康受试者中卡托普利生物利用度的影响。

Effect of food on the bioavailability of captopril in healthy subjects.

作者信息

Singhvi S M, McKinstry D N, Shaw J M, Willard D A, Migdalof B H

出版信息

J Clin Pharmacol. 1982 Feb-Mar;22(2-3):135-40. doi: 10.1002/j.1552-4604.1982.tb02661.x.

DOI:10.1002/j.1552-4604.1982.tb02661.x
PMID:7040498
Abstract

14C-Captopril was administered as 100-mg tablets to 12 subjects in a two-way crossover study in which subjects were either fasted or were given a standard meal immediately prior to dosing. Based on blood level and urinary excretion data, both the absorption of total radioactivity and the bioavailability of captopril were decreased approximately 35 to 40 per cent after a meal. Whether this moderate decrease in the absorption and the bioavailability of captopril caused by food is of clinical significance has not yet been determined.

摘要

在一项双向交叉研究中,12名受试者服用了100毫克片剂的14C-卡托普利,受试者在给药前要么禁食,要么立即给予标准餐。根据血药浓度和尿排泄数据,进食后总放射性的吸收和卡托普利的生物利用度均降低了约35%至40%。食物引起的卡托普利吸收和生物利用度的这种适度降低是否具有临床意义尚未确定。

相似文献

1
Effect of food on the bioavailability of captopril in healthy subjects.食物对健康受试者中卡托普利生物利用度的影响。
J Clin Pharmacol. 1982 Feb-Mar;22(2-3):135-40. doi: 10.1002/j.1552-4604.1982.tb02661.x.
2
Absorption and bioavailability of captopril in mice and rats after administration by gavage and in the diet.
J Pharm Sci. 1981 Aug;70(8):885-8. doi: 10.1002/jps.2600700813.
3
Captopril kinetics.卡托普利动力学
Clin Pharmacol Ther. 1982 Apr;31(4):452-8. doi: 10.1038/clpt.1982.59.
4
Disposition of captopril in normal subjects.卡托普利在正常受试者体内的处置情况。
Clin Pharmacol Ther. 1980 May;27(5):636-41. doi: 10.1038/clpt.1980.90.
5
Impairment of captopril bioavailability by concomitant food and antacid intake.同时摄入食物和抗酸剂会降低卡托普利的生物利用度。
Int J Clin Pharmacol Ther Toxicol. 1984 Nov;22(11):626-9.
6
Captopril: pharmacology, metabolism and disposition.卡托普利:药理学、代谢与处置
Drug Metab Rev. 1984;15(4):841-69. doi: 10.3109/03602538409041080.
7
Tissue distribution of 14C- and 35S-captopril in rats after intravenous and oral administration.静脉注射和口服给药后,14C-和35S-卡托普利在大鼠体内的组织分布。
Xenobiotica. 1985 Jan;15(1):51-6. doi: 10.3109/00498258509045334.
8
Blood concentration and urinary excretion of captopril (SQ 14,225) in patients with chronic renal failure.慢性肾功能衰竭患者中卡托普利(SQ 14,225)的血药浓度及尿排泄情况。
Hypertension. 1981 Jul-Aug;3(4):456-9. doi: 10.1161/01.hyp.3.4.456.
9
Disposition of zofenopril calcium in healthy subjects.健康受试者中佐芬普利钙的处置情况。
J Pharm Sci. 1990 Nov;79(11):970-3. doi: 10.1002/jps.2600791105.
10
Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states.一种新型血管紧张素I转换酶抑制剂(阿拉普利)在禁食或进食状态下口服给药后的药代动力学。
Clin Pharmacol Ther. 1985 Oct;38(4):462-8. doi: 10.1038/clpt.1985.205.

引用本文的文献

1
High-performance liquid chromatography method for measuring Captopril: an empirical study on hydrogel film permeability test.测定卡托普利的高效液相色谱法:水凝胶膜渗透性试验的实证研究。
Daru. 2024 Dec 20;33(1):8. doi: 10.1007/s40199-024-00552-9.
2
Development and evaluation of physiologically based pharmacokinetic drug-disease models for predicting captopril pharmacokinetics in chronic diseases.开发和评估基于生理学的药物疾病药代动力学模型,以预测卡托普利在慢性病中的药代动力学。
Sci Rep. 2021 Apr 21;11(1):8589. doi: 10.1038/s41598-021-88154-2.
3
Food-drug interactions.
食物-药物相互作用
Drugs. 2002;62(10):1481-502. doi: 10.2165/00003495-200262100-00005.
4
Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.影响口服给药后药物吸收的药物、食物及制剂相互作用。临床意义。
Clin Pharmacokinet. 1999 Mar;36(3):233-54. doi: 10.2165/00003088-199936030-00004.
5
Ferrous sulphate interacts with captopril.硫酸亚铁与卡托普利相互作用。
Br J Clin Pharmacol. 1998 Oct;46(4):377-81. doi: 10.1046/j.1365-2125.1998.t01-1-00794.x.
6
Drug-food interactions in hospitalised patients. Methods of prevention.住院患者的药物-食物相互作用。预防方法。
Drug Saf. 1998 Jun;18(6):383-93. doi: 10.2165/00002018-199818060-00001.
7
Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.卡托普利。关于其在心肌梗死后及缺血性心脏病中的药理学和治疗效果的综述。
Drugs Aging. 1995 Sep;7(3):226-53. doi: 10.2165/00002512-199507030-00007.
8
Pharmacokinetic drug interactions with ACE inhibitors.与血管紧张素转换酶抑制剂的药代动力学药物相互作用。
Clin Pharmacokinet. 1993 Jul;25(1):20-58. doi: 10.2165/00003088-199325010-00003.
9
Pharmacokinetics and biochemical efficacy of idrapril calcium, a novel ACE inhibitor, after multiple oral administration in humans.新型血管紧张素转换酶抑制剂依那普利钙多次口服给药后在人体内的药代动力学和生化效应
Br J Clin Pharmacol. 1994 Nov;38(5):421-5. doi: 10.1111/j.1365-2125.1994.tb04377.x.
10
Interactions affecting drug absorption.影响药物吸收的相互作用。
Clin Pharmacokinet. 1984 Sep-Oct;9(5):404-34. doi: 10.2165/00003088-198409050-00002.